Medicalgorithmics continues its dynamic growth – revenue up 38% y/y in Q3, driven by sales in the US: +76% y/y.
Medicalgorithmics, a leader in cardiac diagnostics software listed on the Warsaw Stock Exchange, has presented its estimated revenues for the third quarter, which amounted to nearly PLN 7.2 million, up 38% year-on-year. The medtech company is intensifying its period of dynamic growth, driven by record interest and sales of software based on innovative AI algorithms, mainly in the United States, where revenues are growing by as much as 76%. Since the beginning of 2025, Medicalgorithmics has already signed 17 agreements with new customers, including three on the US market. The new agreements, including one with one of the largest US IDTFs, are already translating into results, and the company anticipates further growth in revenues from their implementation in the fourth quarter and subsequent periods.